Loading...
XJPX
3141
Market cap3.66bUSD
May 28, Last price  
2,552.50JPY
1D
-0.10%
1Q
13.77%
Jan 2017
43.00%
IPO
1,023.11%
Name

Welcia Holdings Co Ltd

Chart & Performance

D1W1MN
P/E
20.03
P/S
0.44
EPS
127.42
Div Yield, %
1.37%
Shrs. gr., 5y
-0.14%
Rev. gr., 5y
9.33%
Revenues
1.22t
+6.38%
198,928,000,000238,752,000,000270,816,000,000293,378,000,000334,393,000,000380,461,000,000528,402,000,000623,163,000,000695,268,000,000779,148,000,000868,280,000,000949,652,000,0001,025,947,000,0001,144,278,000,0001,217,339,000,000
Net income
26.45b
-2.14%
2,154,000,0003,524,000,0004,544,000,0005,899,000,0007,669,000,0007,454,000,0009,527,000,00014,451,000,00017,166,000,00017,423,000,00022,802,000,00027,999,000,00026,453,000,00027,030,000,00026,451,000,000
CFO
46.53b
-22.83%
5,466,000,00013,245,000,00011,635,000,0007,924,000,00030,447,000,00016,519,000,00015,031,000,00033,303,000,00035,902,000,00034,872,000,00070,156,000,00046,396,000,00016,228,000,00060,296,000,00046,529,000,000
Dividend
Aug 28, 20250 JPY/sh
Earnings
Jul 07, 2025

Profile

Welcia Holdings Co., Ltd., together with its subsidiaries, operates a chain of drug stores with dispensing pharmacies in Japan. Its stores primarily sell OTC, healthcare/nursing care, baby, and health food products, as well as dispensing, cosmetics, household goods, food, and other products. The company also offers counseling, late-night, and long-term care services, as well as home-visit bathing and nursing care support services. In addition, it rents and sells welfare equipment; and provides housing services for elderly people. As of February 28, 2022, the company operated 2,468 stores. Welcia Holdings Co., Ltd. was incorporated in 2008 and is headquartered in Tokyo, Japan. Welcia Holdings Co., Ltd. is a subsidiary of Aeon Co., Ltd.
URL
https://www.welcia.co.jp/ja/index.html
IPO date
Sep 01, 2008
Employees
14,865
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2024‑022023‑022022‑022021‑022020‑022019‑022018‑022017‑022016‑02
Income
Revenues
1,217,339,000
6.38%
1,144,278,000
11.53%
Cost of revenue
1,150,032,000
822,932,000
Unusual Expense (Income)
NOPBT
67,307,000
321,346,000
NOPBT Margin
5.53%
28.08%
Operating Taxes
13,996,000
17,505,000
Tax Rate
20.79%
5.45%
NOPAT
53,311,000
303,841,000
Net income
26,451,000
-2.14%
27,030,000
2.18%
Dividends
(6,912,000)
(6,502,000)
Dividend yield
1.18%
1.04%
Proceeds from repurchase of equity
(7,858,000)
2,757,000
BB yield
1.34%
-0.44%
Debt
Debt current
23,215,000
22,425,000
Long-term debt
101,782,000
107,931,000
Deferred revenue
7,000
Other long-term liabilities
25,061,000
24,177,000
Net debt
93,222,000
95,988,000
Cash flow
Cash from operating activities
46,529,000
60,296,000
CAPEX
(18,358,000)
(19,801,000)
Cash from investing activities
(22,028,000)
(36,068,000)
Cash from financing activities
(26,812,000)
(14,849,000)
FCF
35,624,000
284,289,000
Balance
Cash
30,533,000
32,854,000
Long term investments
1,242,000
1,514,000
Excess cash
Stockholders' equity
201,623,000
181,785,000
Invested Capital
352,124,000
331,835,000
ROIC
15.59%
99.01%
ROCE
19.09%
96.69%
EV
Common stock shares outstanding
207,060
209,071
Price
2,826.00
-5.14%
2,979.00
-2.81%
Market cap
585,151,560
-6.05%
622,822,509
-2.53%
EV
685,027,560
725,282,509
EBITDA
91,699,000
344,571,000
EV/EBITDA
7.47
2.10
Interest
723,000
600,000
Interest/NOPBT
1.07%
0.19%